Pharmaceutical Blister Packaging to Expand 6.5% Annually Through 2021

Single dose packaging of solid oral prescription drugs will continue to account for the largest usage

News provided by

Jul 18, 2017, 14:00 ET

CLEVELAND, July 18, 2017 /PRNewswire/ -- Demand for pharmaceutical blister packaging is forecast to expand 6.5% per year to over $4.4 billion in 2021, representing 12.9 billion units. The single dose packaging of solid oral prescription drugs will continue to account for the largest usage whether dispensed directly to patients, tested in clinical trials, distributed as physicians' samples or administered in hospitals. Blister packs are also widely employed as high visibility containers for over-the-counter (OTC) tablets, caplets, and capsules sold in quantities of 50 or fewer. These and other trends are presented in Pharmaceutical Packaging Market in the US, 12th Edition, a new study from The Freedonia Group, a Cleveland-based industry research firm.

In OTC drug packaging applications, growth prospects for blister packaging will benefit from recent and forthcoming switches of previously prescription-only drugs to nonprescription distribution. For example, Xyzal (levocetirizine dihydrochloride), a leading allergy treatment, received FDA approval for OTC sale in January 2017. The OTC version of this medication is sold in a 35-tablet compartment blister pack.

The following factors will spur growth for pharmaceutical blister packaging:

Ongoing improvements in materials and design capabilities
Advantages related to patient drug adherence, prevention of institutional drug distribution errors, barrier protection, child resistance, and security
Advances in processing and filling equipment
Accelerating growth in oral medication demand spurred by the introduction of new chronic care medicines and the expansion of prescription drug coverage

More information about the study is available at https://www.freedoniagroup.com/industry-study/pharmaceutical-packaging-in-the-us-by-product-and-market-12th-edition-3523.htm

Related studies include:
#3529 Packaging Films Market in the US (to be published July 2017)
#3522 Converted Flexible Packaging Market in the US, 14th Edition (May 2017)

About The Freedonia Group, a division of MarketResearch.com – The Freedonia Group is a leading international industrial research company publishing more than 100 studies annually. Since 1985, we have provided research to customers ranging in size from global conglomerates to one-person consulting firms. More than 90% of the industrial companies in the Fortune 500 use Freedonia Group research to help with their strategic planning. Additional Packaging studies can be purchased at www.freedoniagroup.com, www.marketresearch.com and www.profound.com.

Press Contact:
Corinne Gangloff
+1 440.684.9600
[email protected]

SOURCE The Freedonia Group